JAZZ

Jazz Pharmaceuticals plc NMS · JAZZ

$251.24 +7.77 (+3.19%)

Extended · +1.49σ

+ Compare Open in Sniper

Valuation

Market cap $15.8B

P/E (ttm) 2093.6

Forward P/E 9.8

Beta (5y) 0.32

Shares out 62.8M

Div yield —

Profitability & returns

ROE 0.7%

Net margin 0.7%

FCF margin 30.1%

Debt / equity 1.20

Trading information

Last price $251.24

Day range $242.11 – $251.44

52-wk range $161.38 – $251.44

Avg volume 0.9M

RSI (2) 81.6

Trend zone Extended

52-week range · today's price

$161.38$251.44

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-03

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the trea…